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ABSTRACT 
 BACKGROUND AND OBJECTIVES: 
The clinical profile of patients with hypertensive emergencies 
presenting to hospitals in a developing country like ours is poorly 
known. 
The objective of the present study was to evaluate the modes of 
presentations, clinical profile and spectrum of target organ damage in 
patients with hypertensive emergencies. 
METHOD:  
This descriptive study was done at Coimbatore medical college 
over the period of one and half years. 
The study population included patients admitted in this hospital 
with severely elevated blood pressure with clinical or laboratory 
evidence of acute target organ damage. The clinical and laboratory 
profile of 50 of these patients were evaluated. 
 
RESULTS: 
Males had higher chances of developing a hypertensive 
emergency compared to females. 
The commonest presenting symptoms were chestpain and 
dyspnoea, neurological deficit. 
Majority of the patients were known hypertensives. 
Higher levels of blood pressure at presentation were associated 
with an adverse outcome. Acute LVF was the commonest target organ 
damage observed. An in hospital mortality of 12% was observed in 
the present study. 
 
INTERPRETATION AND CONCLUSION: 
Known hypertensive are at a higher risk of presenting with acute 
target organ damage associated with a chestpain. Acute LVF is the 
commonest form of target organ damage encountered in the present 
study. 
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INTRODUCTION 
 
 
Hypertension affects individuals of all classes and across all the 
groups.The relationship between blood pressure and risk of cardiovascular 
disease events is continuous and independent of other risk factors. 
 
It is the number one reason for an office visit to a physician; it accounts 
for the most drug prescriptions, it is a major risk factor for heart disease and 
stroke, which are the first and third leading causes of death in the developing 
countries and it is the number one attributable risk for death throughout the 
world. 
 
At the same time, it is both preventable and treatable in the majority of 
patients. Despite these impressive statistics, hypertension continues to be 
neglected. 
 
Hypertension is present in all populations. It has been estimated that 
hypertension accounts for 6% of deaths worldwide.  
 
Hypertension doubles the risk of cardiovascular diseases, including 
coronary heart disease (CHD), congestive heart failure (CHF), ischemic and 
haemorrhagic stroke, renal failure, and peripheral arterial disease. 
 
Hypertensive emergency can be an end result of chronic 
hypertension,non-compliance of drugs or initial presentation of essential 
hypertension. 
 
It’s also seen that the incidence of hypertensive emergencies are 
increasing. 
 
This study is done to find out various modes of presentation and clinical 
profile of hypertensive emergencies in our hospital. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
AIMS &OBJECTIVES 
This study is to find out the various modes of presentation and clinical 
profile of hypertensive emergencies in Coimbatore medical college. 
 
A number of cardiovascular,pulmonary and neurological symptoms are 
found to be associated with patients in hypertensive emergency with target 
organ involvement. 
 
Due to association of hypertensive emergencies with various 
cerebral,cardiac and renal complications here is an need to recognise this 
condition so as to reduce the burden associated with it in terms of increased 
morbidity and mortality. 
 
And probable cause for this hypertensive crisis also going o be evaluated. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
REVIEW OF LITERATURE  
 
Affecting 1 billion people worldwide, hypertension remains the most 
common, readily identifiable, and reversible risk factor for myocardial 
infarction, stroke, heart failure, atrial fibrillation, aortic dissection, and 
peripheral arterial disease.  
 
Recent data from Framingham hert study suggest that individual who are 
normotensive at 55 years of age have a 90% lifetime risk for developing 
hypertension.26 
 
Because of escalating obesity and population aging, the global burden of 
hypertension is rising and projected to affect 1.5 billion persons—one third of 
the world's population—by the year 2025. 2 
 
It was mahomed of guy’s hospital London who in  1879 advocaed of 
kidney disease based on his personal observations and intuitive arguments.27 
practical measurement  of blood pressure by clinician came f=some time later 
after the invention of the pneumatic arm cuff by riva-roccl of torino in 1896.28 
 Currently, high blood pressure (BP) causes about 54% of stroke and 47% 
of ischemic heart disease worldwide. Thus, high BP remains the leading cause 
of death worldwide and one of the world's great public health problems. 
 
The asymptomatic nature of the condition delays diagnosis. The evidence 
for treaing severe hypertension continues to grow,which clearly shows that 
overall morbidity and mortality improves with treatment.29 
 
Effective treatment requires continuity of care by a knowledgeable 
physician and frequent medical checkups, which are less common in men and 
low-income minorities.  
 
For all these reasons, BP is controlled to a value below 140/90 mm Hg in 
less than one third of affected individuals, even in higher-income countries with 
the most advanced systems of health care. 
 
The symptoms and signs of hypertensive crises are usually dramatic , 
likely reflecting acute damage to endothelium and platelet activation. However, 
some patients may be relatively asymptomatic, despite markedly elevated 
pressure and extensive organ damage.  
 
Young black men are particularly prone to hypertensive crisis, with 
severe renal insufficiency. Even in elderly persons, however, hypertension can 
initially present in an accelerated-malignant phase. If left untreated, patients die 
quickly of brain damage or more gradually of renal damage.  
 
Before effective therapy was available, fewer than 25 percent of patients 
with malignant hypertension survived 1 year and only 1 percent survived 5 
years. With therapy, including renal dialysis, more than 90 percent survive 1 
year and about 80 percent survive 5 years 
 
Research shows that about 1% of hypertensive patients contract 
hypertensive crisis,11,12 which could be a life-threatening event.21,22 
 
Recent clinical trials have demonstrated that effective BP control 
can be achieved in most patients who are hypertensive, but the majority will 
require two or more antihypertensive drugs.45,46 
 Staging of Blood Pressure 
According to the 2003 guidelines of the Seventh Report of the Joint 
National Committee on Prevention, Detection, Evaluation, and Treatment of 
High Blood Pressure (JNC 7), which are still in effect until the publication of 
JNC 8, BP is staged as normal, prehypertension, or hypertension by the average 
of two or more readings taken at two or more office visit.1 
 
Staging of Blood Pressure (JNC7) 
table 1: 
BP STAGE SYSTOLIC BP (mm Hg)  DIASTOLIC BP (mm Hg) 
Normal <120 <80  
Prehypertension  120-139    
  
   80-89 
Stage 1 140-159 90-99  
Stage 2 ≥160 ≥100 
 
 
Hypertensive emergency: 
Hypertensive emergency is defined as the association of an extremely 
elevated blood pressure with physical or laboratory findings that indicate acute 
or ongoing target organ damage.5 
 
It is important to note that no level of BP is given that automatically 
demands emergent treatment unless associated with target organ damage.1 
 
Clinical Characteristics of Hypertensive Crisis 24 
• Blood pressure—usually > 140 mm Hg diastolic  
• Funduscopic findings—hemorrhages, exudates, papilledema  
• Cardiac findings—prominent apical impulse, cardiac enlargement, 
congestive heart failure  
• Renal findings—oliguria, azotemia 
• Gastrointestinal findings—nausea, vomiting  
• Hematological findings—microangiopathichemolysis 
 
 
 
Pathogensis: 25 
Early studies in animals and humans by Strandgaard and Paulson have 
elucidated the mechanism of hypertensive encephalopathy.  
First, they directly measured the caliber of pial arterioles over the cerebral 
cortex in normotensive cats whose BP was varied over a wide range of infusion 
by vasodilators or A II. As the pressure fell, the arterioles became dilated; as the 
pressure rose, they became constricted.  
 
Thus, constant cerebral blood flow was maintained by means of 
autoregulation, which depends on the cerebral sympathetic nerves. However, 
when mean arterial pressure rose above 180 mm Hg (i.e., 220/110), the tightly 
constricted vessels could no longer withstand the pressure and suddenly dilated. 
 
Dilation began in an irregular manner, first in areas with less muscle tone 
and then diffusely, with production of generalized vasodilation. This 
breakthrough of cerebral blood flow hyperperfuses the brain under high 
pressure and thereby causes leakage of fluid into the perivascular tissue, 
resulting in cerebral edema and the syndrome of hypertensive encephalopathy. 
 
Hypertensive urgency: 
 Hypertensive urgency is a situation with markedly elevated blood 
pressure but without severe symptoms or progressive target organ damage.2 
 
These patients must be carefully evaluated and monitored for 
hypertension induced heart and kidney damage and for identifiable cause for 
hypertension.  
 
Chronic hyperesives who do not adhere to therapy may have blood 
pressures much higher that 230/130 mm Hg without acute target organ damage 
and therefore may be treated as hypertensive urgency with reinstituting drug 
therapy.30 
 
The term malignant hypertension has been emphasized in reference to the 
association with encephalopathy or nephropathy with retinopathy.31 
 
Incidence: 
 Zampglione et al in their study on prevalence and clinical presentation of 
hypertensive urgencies and emergencies noticed that hypertensive crisis account 
for 27% of all medical emergencies in an emergency department,out of which 
24% fall in the category of hypertensive emergencies. 6 
  
Sobrino j et al studied prevalence,forms of clinical presentation and 
treatment of arterial hypertension noted that 19.5% of the patients studied by 
them presented with an hypertensive emergency. 9 
 
Martin et al in their study”hypertensive crisis prfile prevalence and 
clinical presentations”,differed in their finding in that hay found the prevalcne 
of hypertensive crisis to be 1.7% of all clinical emergencies ou of which 39.6% 
being hypertensive emergencies.32 
 
It has been observed taht approximately only less than 1% of the 
diagnosed hypertensive [atients experiences hypertensive urgency or emergency 
situations.33 
 
Bennet et al in thiestudy on hypertensive emergencies found that 93% of 
patients presenting in hypertensive emergencies had previously been diagnosed 
as having chronic hypertension,a dn concluded tah improved management of 
pre-existing  known hypertension could lower the incidence of hypertensive 
emergencies.34 
 
Adequate controm of hypertension remains elusive one important reason 
being the asymptomatic nature of the disease for the first 15-20 years even as it 
hypertension and associated coronary vascular disease seems to be increasing.35 
  
The situation in the Indian subcontinent and rest of the developing 
countries is different from hat of the western world. Where the burden offered 
by hypertension and associated coronary vascular disease seems to be 
increasing.7 
 
Incidence may be dependent on drug withdrawal,use of intoxicants and 
due to other precipitating factors.36 
 
 The number of known hypertensives who discontinued their 
antihypertensive medications were 12.75% in the study by cerillo et al 13  and 
37.5% and 25% in studies by sobrino et al and zampglione et al respectively. 
 
Hypertension in older persons 
 
Hypertension occurs in more than two-thirds of individuals after age 65.54 
This is also the population with the lowest rates of BP control.53 
 
Treatment recommendations for older people with hypertension, 
including those who have isolated systolic hypertension, should follow the same 
principles outlined for the general care of hypertension. In many individuals, 
lower initial drug doses may be indicated to avoid symptoms; however, standard 
doses and multiple drugs are needed in the majority of older people to reach 
appropriate BP targets. 
 
Hypertension in women 
Oral contraceptives may increase BP, and the risk of hypertension 
increases with duration of use. Women taking oral contraceptives should have 
their BP checked regularly.  
 
Development of hypertension is a reason to consider other forms of 
contraception. In contrast, menopausal hormone therapy does not 
raise BP.55 
 
Modes of presentation: 
Different manifestation of Hypertensive emergencies: 19 
• Hypertensive encephalopathy 
• Acute aortic dissection 
• Acute myocardial infarction 
• Acute coronary syndrome 
• Pulmonary oedema with respiratory failure 
• Severe pre-eclampsia, HELLP syndrome, eclampsia 
• Acute renal failure 
• Microangiopathichemolyticanemia 
• HELLP, Hemolysis, elevated liver enzymes, low platelets. 
 
A number of cardiovascular,pulmonary and neurological symptoms are 
found to be associated with patients in hypertensive emergencies due to the 
presence of acute ongoing target organ damage. 
 
Focal neurological deficits,dyspnoea,chestpain,headache and loss of 
vision are considered as the commonest symptoms with which patients in 
hypertension related acute target organ damage. 
 Chestpain(27%) was the commonest symptom zampgloine et al noticed 
in their study,followed by dyspnoea(22%) and neurological deficit(21%). 
 
Study by martin j et al differs from the above mentioned in that they 
noticed a neurological deficit(48%) as the commonest mode of presentation 
followed by dyspnoea(25%) and chest pain in(18%). 
 
Hypertensive Heart Disease 
Hypertension may contribute to CAD more than is commonly realized 
because hypertensives have more silent ischemia and unrecognized myocardial 
infarctions, and patients with acute myocardial infarction often have pre-
existing hypertension that evaded detection or treatment. 
 
There have been tremendous advances in our understanding of the cell 
and molecular mechanisms underlying pressure overload cardiomyocyte 
hypertrophy.Moreover, the structural abnormalities in the hypertensive heart are 
not limited to myocyte hypertrophy. They also include medial hypertrophy of 
the intramyocardial coronary arteries as well as collagen deposition leading to 
cardiac fibrosis. These changes result in part from pressure overload and in part 
from the neurohormonal activation that contributes to hypertension. 
 
In the hypertrophied hypertensive heart, coronary blood flow is normal at 
rest but vasodilator reserve becomes impaired when myocyte mass outstrips the 
blood supply. Even in the absence of CAD, coronary vasodilator reserve is 
blunted or absent, leading to subendocardial ischemia under conditions of 
increased myocardial oxygen demand. The combination of subendocardial 
ischemia and cardiac fibrosis impairs diastolic relaxation, leading to 
exertionaldyspnea and diastolic heart failure. 
 
Before the advent of effective drug therapy for hypertension, beginning in 
the late 1950s, heart failure caused most deaths from hypertension. With better 
management of hypertension, there has been a dramatic reduction in 
hypertension-related deaths from heart failure and a significant delay in its 
onset. 
 
Hypertension remains the most common cause of diastolic heart failure. 
In addition, hypertension indirectly leads to systolic heart failure by virtue of its 
being a major risk factor for myocardial infarction. It is unclear whether mild or 
moderate hypertension alone, without myocardial infarction, leads to systolic 
heart failure. 
 
Pre-existing hypertension increases the case-fatality rate associated with 
an acute myocardial infarction and substantially increases the risk of 
haemorrhagic stroke during thrombolytic therapy, especially when systolic BP 
exceeds 175 mm Hg. 
 
On the electrocardiogram, LVH with strain is a serious harbinger of new-
onset heart failure and heart failure death. 
 
Echocardiography detects LVH more sensitively than 
electrocardiography does.  
 
Large-Vessel Disease  
Hypertension also constitutes a major risk factor for majority of patients 
with aortic dissection (distal more than proximal dissection), abdominal aortic 
aneurysm, and peripheral arterial disease.  
 
Cerebrovascular Disease  
Hypertension is a major risk factor for stroke and dementia.1 
 
Hypertensive encephalopathy is thought o be due to cerebral oedema 
resulting from a failure of cerebral blood flow auto regulation.15 
 
Hypertension accounts for 50% of strokes. In hypertensives, 80% of 
strokes are ischemic (thrombotic or embolic) and 20% are haemorrhagic.  
 
The risk of hemorrhagic stroke is increased in patients with uncontrolled 
hypertension.56 
 
In normal individuals,cerebral blood flow remains fairly constant for a 
mean arterial pressure from approximately 60mm hg to up to 150mmhg. When 
the meanarterial pressure decreased to less than the lower limits of 
autoregulation. The brain becomes hypoperfused and cerebral hypoxia occurs. 
With symptoms such as dizziness,nausea and syncope.  
 
In chronically hypertensive individuals,the lower limit of autoregulation 
is increased and autoregulation might fail at mean arterial pressures that are well 
tolerated in nonhypertensive individuals.9 
 
It has been observed that he lower limit of the autoregulation curve tends 
to be approximately 25% of mean arterial pressure.This has led to the general 
recommendation that the mean arterial pressure be acutely decreased by no 
more than 20% to 25%.10,16 
 
When diastolic blood pressure exceeds 140 mm Hg, rapidly progressive 
damage to the arterial vasculature is demonstrable experimentally, and a surge 
of cerebral blood flow may rapidly lead to encephalopathy. 24,38 
 
Dementia and cognitive impairment occur more commonly in people 
with hypertension. Reduced progression of cognitive impairment may occur 
with effective antihypertensive therapy.58,59 
 
Intracerebral haemorrhage is more than twice as common as 
subarachnoid haemorrhage and is much more likely o result in death or major 
disability than cerebral infarction or SAH advancing age and hypertension are 
the most important risk factors for ICH.12,17 
 
There are reports of adverse outcomes with acutely decreasing the blood 
pressure in hypertensive patients by using short acing anti hypertensive 
drugs.39,40 
 
Chronic Kidney Disease 
Hypertension follows only diabetes as a risk factor for CKD.  
 
Microalbuminuria is a sensitive early marker of kidney damage and a 
powerful independent predictor of cardiovascular complications from 
hypertension. 
 
Most patients with hypertension-associated CKD die of heart attack or 
stroke before renal function deteriorates sufficiently to require chronic 
hemodialysis. 
 
The Benefits Of Treating Hypertension 
It is well established that treating hypertension reduces the rate of strokes 
by 35 to 40%, coronary heart disease events by 20 to 25%, and congestive heart 
failure by up to 50%, and that the benefits of antihypertensive treatment are 
more closely related to the change of blood pressure than how it is lowered.1,48 
 
In the majority of patients, controlling systolic hypertension, which is a 
more important CVD risk factor than DBP except in patients younger than age 
50.49 
 
Effects of Hypertension Treatment on Morbid Events  
Event     Average % Reduction  
Stroke      35–40%  
Myocardial infarction    20–25%  
Heart failure    50%  
 
The benefits of treating chronic hypertension were clearly identified by 
the historic placebo-controlled VA cooperative study published in 
1967,showing that blood pressure decreasing drugs markedly reduce 
cardiovascular morbidity and mortality3. The evidence base for treating severe 
hypertension continues to grow,which clearly shows that overall morbidity and 
mortality improves with treatment.4 
 
Drug non compliance with prescribed medications and inadequate 
therapy are the most common causes for hypertensive emergency in the primary 
hypertension.20 
 
Factors Related to Poor Blood Pressure Control 
There are multiple reasons, ranging from physiologic to societal, why 
blood pressure control is not better. They can be divided into three general 
categories: factors related to the patient, the healthcare provider, and the 
healthcare system.  
 
 
 
 
 
FACTORS RELATED TO POOR CONTROL OF HYPERTENSION 
Table 2: 
Patient    
   
  
Physician  Health Care System 
Older age  Therapeutic inertia  Poor availability of care  
Resistant hypertension  Inappropriate choice of 
drugs 
 
Poor adherence  Lack of knowledge  
Poor access to care   
 
 
History and Physical Examination and Laboratory Evaluation 
The three main goals of the initial evaluation of the hypertensive patient 
are to  
(1) assess the presence of target-organ damage related to hypertension, 
especially those that might influence choice of therapy 
(2) determine the presence of other cardiovascular risk factors and disease 
(3) evaluate for possible underlying secondary causes of hypertension. 
These goals are usually accomplished by a thorough medical history, physical 
examination, and simple laboratory investigations. 
 
History 
The key issues that need to be addressed in the history include: 
• Duration, age of onset, and previous levels of high blood pressure 
• Previous antihypertensive therapy, its impact on blood pressure and 
adverse effects 
• Symptoms suggestive of secondary causes of hypertension 
• Lifestyle factors, such as dietary intake of fat, salt, alcohol, smoking, and 
physical activity, weight gain since early adult life 
• History of symptoms of neurologic dysfunction, heart failure, coronary 
heart disease, or peripheral arterial target-organ damage 
• Use of medications that influence blood pressure such as oral 
contraceptives, cocaine, amphetamines, steroids, nonsteroidal anti-
inflammatory drugs, erythropoietin, and cyclosporine. 
 
 
Physical Examination: 
In addition to blood pressure measurement, the physical examination 
should search for signs of secondary hypertension and for evidence of organ 
damage.  
 
Blood pressure measurement technique:24 
 
In the office, BP should be measured at least twice after 5 minutes of rest, 
with the patient seated in a chair, the back supported, and the arm bare and at 
heart level.  
 
A large adult-sized cuff should be used to measure BP in overweight 
adults because the standard-sized cuff can spuriously elevate readings.  
 
Tobacco and caffeine should be avoided for at least 30 minutes. BP 
should be measured in both arms to exclude coarctation of the aorta and after 5 
minutes of standing, the latter to exclude a significant postural fall in BP, 
particularly in older persons and in those with diabetes or other conditions (e.g., 
Parkinson's disease) that predispose to autonomic insufficiency. 
 An individual's BP varies widely throughout a 24-hour period and is 
therefore impossible to characterize accurately except by repeated 
measurements under various conditions. Out-of-office readings are the only way 
to obtain a clear picture of a person's usual BP for accurate diagnosis and 
management. 
 
Ambulatory monitoring provides automated measurements of BP over a 
24-hour period while patients are engaging in their usual activities, including 
sleep. 60 
 
Prospective outcome studies in both treated and untreated patients have 
shown that ambulatory BP measurement predicts fatal and nonfatal myocardial 
infarction and stroke better than standard office measurement. 
 
Other signs, such as carotid bruits; motor or sensory defects; fundoscopic 
abnormalities; abnormal cardiac rhythms; ventricular gallop; pulmonary rales; 
dependent oedema; and absence, reduction, or asymmetry of pulses and cold 
extremities, may suggest end organ damage. 
  
WHITE COAT HYPERTENSION. 
Up to one third of patients with elevated office BPs have normal home or 
ambulatory BPs. If the daytime BP is below 135/85 mm Hg (or preferably 
below 130/80 mm Hg) and there is no target organ damage despite consistently 
elevated office readings, the patient has “office-only” or “white coat” 
hypertension, presumably caused by a transient adrenergic response to the 
measurement of BP only in the physician's office. 
 
BP self measurements may benefit patients by providing information on 
response to antihypertensive medication, improving patient adherence with 
therapy.47 
 
 Keith et al described the course and prognosis of patients with 
hypertension according to he degree of retinopathy. These patients were divided 
into four groups (1-4).Patients i group 1 had survival of 70% at seven years;at 
the same time. Group 4 had a 90% morality at 1.5 years.18 
 
 Risks Influencing Prognosis in Patients with Hypertension 
ü Risk Factors for Cardiovascular Disease   
ü Levels of systolic and diastolic blood pressure   
ü Age (yr)—men >55; women >65   
ü Smoking   
ü Dyslipidemia 
ü Family history of premature cardiovascular disease   
ü Abdominal obesity   
ü Diabetes mellitus   
ü C-reactive protein ≥1 mg/dl. 
 
Laboratory Tests: 
Routine investigations before initiation of therapy include urine for 
protein and blood; serum creatinine (estimated glomerular filtration rate [GFR]) 
and electrolytes; fasting blood glucose; fasting lipid profile; and 
electrocardiogram (ECG).  
 
Evaluation of renal status may indicate oliguria and azotemia.37 
 Generally, it is not necessary to do more extensive tests unless blood 
pressure control is not achieved or there are clinical or laboratory clues of 
secondary hypertension.  
 
Echocardiography is also more sensitive than electrocardiography in 
identifying left ventricular hypertrophy. Left ventricular hypertrophy is 
identified by electrocardiography in only 5% o 10% of hypertensives. Whereas 
LVH is found by echocardiography in nearly 30% of unselected hypertensive 
adults and in upto 90% of patients with severe hypertension.11,14 
 
Risk Assessment: 
The key risk factors which need to be considered are age (>55 years male, 
>65 years female), family history of premature cardiovascular disease (age <55 
in men, age <65 years in women), cigarette smoking, dyslipidemia, diabetes, 
obesity (body mass index >30 kg/m2), reduced GFR (<60 mL/min), or presence 
of microalbuminuria.  
 
Whereas hypertension is present in 25 percent of adults in the general 
population, it is present in 75 percent of adults with diabetes and over 90 
percent of those with chronic kidney disease. Either of these two comorbidities 
dramatically increases the cardiovascular risk associated with hypertension, and 
the presence of hypertension greatly accelerates the progression to end-stage 
renal disease. 
 
The 2003 JNC 7 guidelines have recommended a usual BP of 140/90 mm 
Hg as the threshold for initiating antihypertensive medication in most patients, 
with a lower threshold of 130/80 mm Hg for high-risk patients with diabetes or 
chronic kidney disease.50,51 
Serum potassium and creatinine should be monitored at least 1–2 
times/year.52 
 
Followup and Monitoring52 
Once antihypertensive drug therapy is initiated, most patients should 
return for followup and adjustment of medications at approximately monthly 
intervals until the BP goal is reached. More frequent visits will be necessary for 
patients with stage 2 hypertension or with complicating comorbid conditions.  
 
Prognosis:  
 Depending upon risk factors and associated co-morbid conditions and 
drug compliance of the patients. There are numerous medications available for 
treatment,these improvement have led to decrease in one year mortality rate.2 
 
 A patient-centered strategy to achieve the goal and an estimation of the 
time needed to reach goal are important in the prognosis.57 
 
 Lip G.Y, bevers D.G investigated the factors affecting the survival in 
patients with malignant hypertension. Hte most common causes of death were 
renal failure,sroke which was followed by myocardial infarction and heart 
failure.41 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
MATERIALS  AND METHODS 
 
MATERIALS AND METHODS 
The present study was done in patients admitted to Coimbatore medical 
college,Coimbatore,tamilnadu over a period ofone and half years. 
 
Selection criteria: 
Inclusion criteria: 
• Patients above the age of 18 years. 
• Systolic blood pressure of 180mmhg or diastolic blood pressure of 
110mmhg 
• Evidence of target organ damage,either clinically or on laboratory 
findings. 
 
Exclusion criteria: 
• Patients less than 18 years. 
• Chronic renal failure,valvular heart disease,other secondary causes of 
hypertension. 
 
 
 
Source of data: 
Fifty patients admitted to Coimbatore medical college hospital with 
clinical and laboratory evidence of hypertensive emergency. 
 
Type of study:  
Descriptive study 
Study protocol: 
Data was collected from fifty patients admitted in this hospital from over 
aperiod of one and half years. 
 
Patients who presented with an elevated blood pressure of systolic blood 
pressure of >180mmhg or diastolic blood pressure >110mm Hg,with history of 
acute target organ damage or with a laboratory evidence of acute target organ 
damage were included in the study. 
 
A detailed history was taken with which included presenting 
sympotomalogy,hypertension related history with emphasis on drug 
compliance. 
 The information thus obtained was recorded in the proforma a copy of 
which is furnished in the annexure. Blood pressure was recorded in these 
patients at the time of admission,after one hour,after 24 hours and at the time of 
discharge. 
 
Detailedclinical examination was done in these patients with examination 
of respiratory system,cardiovascularsystem,abdomen and central nervous 
system. 
 
Clinical examination also included fundoscopic examination in all the 
patients.Blood samples of these patients were evaluated for biochemcial 
abnormalities. 
 
The routine investigation done in these patients were the HB%, 
totalcount, differential count, ESR, bloodsugar, serumurea,serum creatinine 
,serum electrolytes,serum total cholesterol, serum triglycerides, HDL, LDL, 
microalbunuria and urine analysis. 
 
All the patients also underwent chest x-ray,urineanlaysis and serum 
electrolyes. 
 
Patients with clinical suspicion of neurological deficits were evaluated 
with computed tomography of the brain,patients with cardiovascular 
dysfunction clinically were evaluated with ECHO and patient with renal 
dysfunction underwent renal sonography. 
 
The collected data was analysed using Microsoft excel software. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS & ANALYSIS  
 
RESULTS & ANALYSIS 
 
Results and analysis: 
Among the fifty patients in the present study,29
male:female ratio is almost 1.4:1.
 
Figure 1:sex distribution  
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The mean age of the patients was 58.The age varied from 38 to 70 in 
males and 39 to 78 in females. The mean age for males and females were 54 
and 58.5 years respectively. The age distribution is given in table 2 below.
 
In the age distribution patients,patients less than age of 50 were 34%(17 
pts) and more than 50 years were 66%.
Figure 2: age distribution 
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 In the present study the presenting symptoms in
chestpain& dyspnoea.  
 
The commonest presenting complaints were chestpain&dyspnoea(36%)  
and followed by neurological symptom(28%).
 
Figure 3:presenting symptoms
 
 
 
0
5
10
15
20
25
30
35
40
chestpain & 
dyspnoea
neurological  
36
28
 these patients were 
 
 
chestpain neurological 
df & 
convulsions
dyspnea vision df
12 12 10
2
 
  
 
 
 
Among patients with neurological deficit,neurological damage in
ischemic infarct(20%),intra cerebral haemorrhage(12%),SAH(4%).
 
 
Figure 4:neurological manifestation
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 Among the target organ involv
ICH(20%),ischemic infarct(18%),MI(14%),Unstable angina(12%), SAH(4), 
hypertensive encephalopathy(4%),vision defect(2%).
Figure 5:target organ involvement
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Hypertensive status: 
 
Among the patients 44 patients (88%) were known 
hypertensives,remaining patients(12%) were not a known hypertensive. 
 
Figure 6:hypertensive status
 
 
 
 
HYPERTENSIVE STATUS
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 Of the 50 patients studied 44 patients were known hypertensives,among 
them 27 patients(61%) were discontinued antihypertensives before the 
incident,remaining 17 patients(39%) were continued their medication.
 
 
Figure 7: drug compliance
Among the 50 patients 14 patients(28%) were having diabetes mellitus 
and 14 patients(28%) had dyslipidemias.
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 Out of 50 patients with hypertensive emergencies,6 patients died before 
discharge. Hospital mortality was 12%.
intracerbral haemorrhage.
 
Figure 8:outcome  
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DISCUSSION 
 
 
In the present clinical study of hypertensive emergencies in Coimbatore 
medical college,Coimbatore there is mild male predilection for hypertensive 
emergencies. 
 
Marin et al in their study on hypertensive crisis observed that 55% of 
patients were males among patients with hypertensive emergencies. The 
proportion of males in hypertensive emergencies were also higher in the study 
by zampoglione et al. This is probably due to an increased susceptibility of 
males compared with females to hypertension related target organ damage. 
 
This also due to the fact that postmenopausal female hemodynamics is 
not very mush different from the male profile with regard o blood pressure.42,43 
 
The majority of female patients belonged to the postmenopausal age 
group which shows susceptibility of postmenopausal age to end organ damage. 
 
Decade wise distribution of age shows largest groups belonging o the 
fifth and sixth decade at the time of presentation with 30% and 26% 
respectively. 
 Analysing the presenting symptoms, the largest group of patients in the 
present study,presented with a chestpain and dyspnoea and followed by 
neurological deficit. 
 
Zampglione et al in their study had more patients presenting with 
chestpain(36%) and neurological deficit 28% respectively. 
 
Majority of patients in the present study were previously known 
hypertensives (88%).martin et al noticed a large a large number of patients 
(83%) in their study to be previously diagnosed hypertensives. 
 
Zampaglione et al reports a large number, with(92%) of known 
hyperensives among their patients. This evidence confirms that hypertensive 
emergencies were higher in patients with previously known hypertension. This 
also shows that patients with hypertension are at a higher risk of developing a 
hypertensive emergency,more so if they do not adhere to the antihypertensive 
therapy. 
 
A. Rafighdoost MD, et al study showed discontinuing of medications to 
be of utmost importance in precipitating hypertensive crisis. 75% of the subjects 
had stopped medications and only 25% had continued them.23 
 
In the present study 61% among he known hypertensives ignored their 
hypertensive status and discontinued antihypertensive medications which would 
have put them at a higher risk for acute target organ damage and hypertensive 
emergency. 
 
Diabetes mellitus and dyslipidemia were the other risk factors present in 
the present group of patients. Patients with diabetes mellitus and dyslipidemia 
were 28% and 28% respectively. 
 
Prevalence of arterial hypertension in diabetic patients is greater when 
compared with that in non diabetic patients(40-50% and 20% respectively).44 
 
Metabolic abnormalities hyperglycemia,hyperinsulinemia and 
dyspilidemia may play role in the pathogenesis and complications of arterial 
hypertension as seen in the present study. 
 Highest recorded systolic blood pressure was 250mm hg with mean 
systolic blood pressure of 215mm Hg. The highest diastolic blood pressure 
recorded was 160mm hg with a mean of 130 mm Hg. 
 
Martin et al in their study reports a mean systolic blood pressure of 
193+/- 26 mm Hg in their patients and a mean diastolic blood pressure 0f 129+/-
12mm hg. 
 
The higher levels of blood pressure would have added to more severe 
target organ damage in these patients with an adverse outcome. 
 
Evaluation of fundus revealed changes ranging from hypertensive 
retinopathy to papilloedema in 50% of patients.Papilloedemawas seen in 12 % 
of patients which is an evidence of ongoing target organ damage in these 
patients. 
 
Microalbunuria was seen in 32% of the patients which puts these patients 
at a higher risk for hypertension related renal disease compared to the patients 
without proteinuria. 
 
Computed tomography of the brain showed intracerebral haemorrhage as 
the commonest cause for the neurological target organ damage followed by 
cerebral infarct and subarachnoid haemorrhage. Voltage criteria suggestive of 
left ventricular hypertrophy on ECG was seen in 20% of patients and 18% had 
left ventricular hypertrophy by echocardiography. 
 
A study done by lip GY et al on complications and survival of 315 
patients with malignant hypertension found low median survival time in patients 
with proteinuria and high serum urea and serum creatinine levels at presentation 
and if left ventricular hypertrophy was detected on electrocardiogram. These 
findings in patient in hypertensive emergency situation may help in 
prognosticating these patients. 
 
Evaluation for target organ damage in patients in the present study 
showed acute LVF(26%) followed by intracerebral haemorrhage(20%),ischemic 
infarct(18%),acute myocardial infarction (14%),Sub arachnoid 
haemorrhage(4%),hypertensive encephalopathy (4%) and vision defect(2%). 
 
Zampglione et al in their study observed target organ damage in the form 
of intracerebralhaemorrhage(4.5%) left ventricular failure(23%).acute ischemic 
stroke(24%) in their patients. 
 
Study by Martin et al shows intracerebralhaemorrhage(17%) left 
ventricular failure (25%),acute ischemic stroke(39%) and acute myocardial 
infarction in(8%) their patients. 
 
The outcome of the study showed an in hospital mortality of 12% among 
these patients. All patients who were expired had intracerebral haemorrhage. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
 ü Majority of patients presenting hypertensive emergency belonged 
to the fifth and sixth decades of age. 
 
ü Males have higher chances of developing hypertensive 
emergencies compared in females. 
 
ü Known hypertensives are at a higher risk of presenting acute target 
organ damage associated with hypertensive emergency. 
 
ü Presence of diabetes mellitus and dyslipidemia increases the 
chance of developing hypertensive emergency. 
 
ü Commonest mode of presentation is with a chestpain and 
dyspnoea. 
 
ü Higher levels of blood pressure at presentation is with a 
neurological deficit. 
 ü Acute LVF is the commonest form of target organ damage 
encountered in the present study. 
 
ü The in-hospital mortality among these patients with hypertensive 
emergency were 12%. Cause for all was mortality was due to 
intracranial haemorrhage.  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY 
  
The clinical profile of patients with hypertensive emergencies presenting 
in hospitals in a developing country like ours is poorly known. 
 
The present study is a descriptive study done a Coimbatore medical 
college,Coimbatore,over a period of one and half years. 
 
The study population included patients admitted to this hospital with 
severely elevated blood pressure  with clinical or laboratory evidence of acute 
target organ damage. 
 
The clinical and laboratory profile of 50% of these patients were 
evaluated. 
 
The commonest presenting symptoms were chestpain and dyspnoea and 
neurological damage. 
 
Majority of the patients were known hypertensives which was also seen 
in other similar studies and confirms that known hypertensives have higher risk 
of developing hypertensive emergencies. 
 
Higher levels of blood pressure at presentation were associated with an 
adverse outcome. Acute LVF was the commonest target organ damage 
observed. 
 
An in-hospital mortality of 12% was observed in the present study. Cause for all 
was mortality was due to intracranial haemorrhage.  
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ANNEXURES 
 
 
PROFORMA  
Name:    Age:    Sex: 
Address:    DOA:    DOD: 
 
Presenting complaints: 
Chestpain 
Site, radiation: 
Character: 
Duration: 
Dyspnoea: 
 PND: 
Neurological deficit: 
 Loss of consiousness 
 Cranial nerve deficit: 
 Motor/sensory deficit 
Pedal oedema: 
Oliguria. Anuria 
Visual deficit 
Others 
Past history: 
Hypertension  
Duration:     treatment  
Medication discontinued : yes/no 
Complications related to hypertension in the past: 
Any other associated illness: 
Other relevant past history: 
General examination 
Pallor icterus 
Cyanosis 
Clubbing 
Oedema 
Lymphadenopathy 
Vital signs: 
Pulse rate:    Respiratory rate: 
Blood pressure on presentation: 
Blood pressure after one hour: 
Blood pressure after 24 hours: 
Blood pressure at discharge: 
Respiratory system: 
Inspection: 
Palpation: 
Percussion: 
Auscultation: 
 
Cardiovascular system: 
Inspection: 
Palpation: 
Percussion: 
Auscultation: 
Abdomen: 
Inspection: 
Palpation: 
Percussion: 
Auscultation: 
Central nervous system: 
Higher mental functions: 
Cranial nerves 
 
 
 
      Right     left  
Motor system 
Bulk UL: 
 LL: 
Tone UL: 
 LL: 
Power UL: 
 LL: 
Deep tendon reflexes 
Plantar: 
Sensory system: 
meningeal signs: 
Fundus: 
Clinical diagnosis: 
Investigations: 
HB%: 
TC:     DC:   ESR: 
Urine analysis: micro/macro albunuria 
Random blood sugar: 
Serum urea: 
Serum creatinine: 
Serum cholesterol: 
Triglycerides: 
LDL cholesterol: 
HDL cholesterol: 
Serum sodium: 
Serum potassium: 
Serum chloride: 
ECG: 
Ultrasound scan(abdomen) 
CT scan(head) 
Diagnosis: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Master chart 
 
 
S.NO 
 
NAME  
 
AG
E 
SEX 
 
IP NO. 
 
 
 
CHE
STP
AIN 
 
DYSP
NEA 
 
NEUR
O 
DEFI
CIT 
 
CON
VUL
SIO
NS 
 
VISUA
L 
DEFI
CIT 
 
H/O 
HTN 
 
HTN 
YRS 
 
HTN 
RX 
 
 
DRU
G  
CO
MPL
INA
CE 
 
DIA
BET
ES 
 
SENSORIUM 
 
BP-0 
HOURS 
MM/HG 
1 SUBRAMANI 45/
M 
24536 P A A A A P 4 CCB P A CONSCIOUS 190/120 
2 SRINIVAS 58/
M 
64874 A P A A A A A NA NA A CONSCIOUS  200/120 
3 DEIVATHAL  65/F 34562 A A P A A P 10 CCB NA A STUPEROUS  220/140 
4 MURUGAN  45/
M 
26474 P P A A A P 1 NA NA P CONSCIOUS  180/110 
5 VASUDEVAN  55/
M   
25378 A A P A A P 2 ACE A A CONSCIOUS  190/120 
6 VELAN  55/
M 
34126 A A P A A P 4 CCB P A CONSCIOUS  180//110 
7 DHANALAKSH
MI 
44/F 21902 P P  A A A P 5  ACE
I 
P A CONSCIOUS  190/114 
8 KALIAPPAN  55/
M 
26731 P A A A A A A NA A A CONSCIOUS  200/124 
9 PATTAHAL  62/F 29803 A A P P A P 2 N/A P A DROWSY 210/110 
10 PONNAN 70/
M 
23415 A P A A A P 10 ACE
I 
NA P CONSCIOUS  190/112 
11 PONAMMAL  78/F 56342 A A P A A P 12  CCB NA  A UNCONSCIO
US  
240/120 
12 CHINNAL  70/F 42315 P P A A A P 3 ARB NA A CONSCIOUS  200/130 
13 PALANIAPPAN 40/
M 
34521 P A A A A P 2 BB A A CONSCIOUS  190/110 
14 THULASI  50/F 31245 A A P P A A A NA  NA A CONSCIOUS  200/120 
15 VADIVU 74/F 21902 P P A A A P 13 BB A P CONSCIOUS  190/140 
16 VIJAYAN  58/
M 
45321 P P A A A P 5 BB/
ACE
I 
A A CONSCIOUS  180/110 
17 MYLATHAL  58/F 26735 A A P P A P 10 CCB P A CONSCIOUS 200/110 
18 DHANDAPANI 55/
M 
28745 P P A A A P 2 BB A P CONSCIOUS  190/110 
19 SARAVANAN  65/
M 
34522 A P A A A P 4 CCB A A CONSCIOUS  200/130 
20 KALIYAMMAL 75/F 45237 A A P A A P 6 CCB 
THI
AZI
DE 
P A STUPEROUS  190/110 
21 SARAWATHY  65/F 43266 A A P A A P A NA NA A CONSCIOUS  190/110 
22 PUSPHARAJ  65/
M 
56332 A P A A A P 8 CCB
/BB 
P P CONSCIOUS  180/110 
23 NEELAVATHY  74/F 45261 P P A A A P 4 CCB
/AR
B 
P P CONSCIOUS  170/120 
24 RAJARAMAN  55/
M 
31002 A A P A A P 2 CCB A A STUPEROUS  190/120 
25 PUSPHA   63/F 25301 P P A A A P 3 ACE
I 
P A CONSCIOUS  200/110 
26 LAKSHMANAN 39/
M 
20110 A A P A A P 2 BB A P CONSCIOUS  220/110 
27 MANICKAM  45/
M  
31092 P A A A A P 6 ACE
I 
A P CONSCIOUS  180/110 
28 ARUMUGAM 55/
M  
59063 P P A A A P 4 ACE
I 
P A CONSCIOUS  190/110 
29 SEENI  42/
M 
52617 A A P A A P 1M
ON 
CCB A A SEMI-
CONSICOUS  
220/140 
30 RANGAN  38/
M 
31526 A P A A P 
BLUR
RING 
OF 
VISIO
N 
NEAR 
DEFE
CT  
P A A A A CONSICOUS  220/160 
31 MUNUSAMY  49/
M 
41526 P A A A A P 5 CCB 
BB 
P P CONSICOUS  210/116 
 
 
 
 
 
 
 
 
 
 
 
 
NEUROL
OGICAL  
DEFICIT 
MENIN
GISM 
FUNDUS CLINI
CAL 
LV 
FAIL
URE  
BP-
1 
HRS 
MM/
HG 
BP-
24 
HRS 
MM/
HG 
BP-
AT 
DIS 
MM/
HG 
UR
EA  
M
G 
CREAT
ININE 
MG 
URI
NE  
MIC.
ALB 
DYS
LIP 
N
A 
K ECG 
A A GARDE 2 A 180/
100 
160/
90 
150/
90 
42 1.2 1+ NIL 1
4
1 
3.
5 
LVH 
ST-T 
CHANGES 
A A GRADE 2 P 190/
110 
150/
90 
140/
80 
55 1.8 2+ MIL
D 
TRI
GLY 
1
3
8 
3.
9 
LVH  
LAFB 
P A PAPILLO
EDEMA 
A 180/
120 
170/
100 
170/
100 
38 1 A NIL 1
3
9 
4.
1 
LVH  
A A NORMAL  A 170/
100 
130/
90 
130/
80 
41 0.8 A NIL  1
4
2 
4.
4 
ST-T 
CHANGES 
P A NORMAL A 140/
100 
140/
100 
130/
90 
32 0.8 1+ NIL  1
4
1 
3.
8 
NORMAL  
P A PAPILLO
EDEMA 
A 140/
100 
130/
100 
130/
90 
30 0.8 A NIL  1
4
0  
4.
0 
NORMAL  
32 KANDASAMY  38/
M  
31829 A A P A A P 1 ACE
I 
P A CONSCiOUS  180/120 
33 MANIMEGALAI  41/F 21029 A A P A A P 2 CCB P A CONSICOUS  200/110 
34 KALLIYAMMAL  67/F  41028 P P A A A A NA NA A A CONSICOUS  194/102 
35 MANIKAMMAL  43/F 50982 A A P P A A A NA  A A COMATOUS  204/106 
36 MUSTAFA  45/
M 
21783 P P A A A P 1 ARB P A CONSICOUS  192/106 
37 PALANATHAL  55/F 26735 A A P A A P 10 CCB P P COMATOUS  184/118 
38 RAMASAMY  45/
M 
20012 P P A A A P 3 PRA
ZOS
IN  
P P CONSICOUS  188/116 
39 JOSEPH  38/
M 
32145 P A A A A P 6 
MO
N 
ARB P P CONSICOUS  190/126 
40 THAYAMMAL  64/F 33980 P P A A A P 15  CCB 
THI
AZI
DES  
P A CONISOIUS  240/108 
41 MEHARUNISHA  45/F 22274 A A P P A P 3 BB P A SEMI 
CONSIOUS  
220/130 
42 MURUGATHAL  50/F 21234 A A P A A A A NA A A CONSICOUS  186/112 
43 VELUSAMY  60/
M  
42516 P P A A A P 8 CCB P A CONSICOUS  198/110 
44 HAMSATH 
BEGAM  
54/F 33445 P P A A A P 4 ARB 
THI
AZI
DES  
P P CONSICOUS  200/104 
45 RAMU 60/
M  
22450 A A P P A P 10 CCB 
BB 
P A CONSICOUS  190/116 
46 PALANIAPPAN  58/
M  
21135 P P A A A P 8 ACE
I 
P P CONSICOUS  250/128 
47 RANGASMMAL   63/F  20192 A A P A A P 5 CCB P A STUPEROUS  220/114 
48 HARIKRISHNAN  60/
M 
20192 P P A A A P 16 CCB P A CONSICOUS  198/120 
49 KALIMUTHU  52/
M 
20921 P P A A A P 4 CCB P A CONSICOUS  184/112 
50 VENGAIYA 
NAIDU  
48/
M 
25641 A A P A A P ^ CCB P A CONSICOUS  192/112 
P A GRADE 1 A 150/
100 
140/
90 
130/
90 
30 1.1 1+ NIL  1
3
9 
4
/
6 
ST-T 
CHANGES 
A A NORMAL  A 150/
100 
140/
90 
130/
90 
32 1.2 A NIL  1
3
8 
3.
9 
ST-T 
CHANGES 
P A PAPILLO
EDEMA 
A 180/
100 
160/
100 
160/
100 
34 0.7 A CHO
L 
1
4
0 
4.
3 
LVH 
A A GRADE 2 P 190/
90 
180/
100 
150/
100 
32 0.9 1+ NIL  1
4
3 
3.
8 
ST-T 
CHANGES  
P P NORMAL  A 200/
100 
190/
110 
180/
110 
45 1.2 2+ NIL  1
4
0 
3.
9 
NORMAL  
A A GRADE 2 P 180/
100 
170/
100 
140/
100 
54 1.5 1+ NIL  1
3
8 
3.
8 
ST-T 
CHANGES  
A A NORMAL  A 160/
100 
140/
90 
130/
80 
34 0.7 A NIL 1
4
5 
3.
3 
ST-T 
CHANGES 
P P NORMAL  A 190/
110 
190/
100 
160/
100 
32 1.1 1+ NIL  1
4
5 
4.
3 
LVH 
A A GRADE 3 A 190/
90 
180/
90  
160/
90 
34 1.2 1+ NIL  1
3
9 
4.
5 
ST-T 
CHANGES 
A A GRADE 1 P 180/
100 
150/
90 
140/
100 
42 1.9 1+ NIL 1
4
3 
5.
2 
ST-T 
CHANGES  
P P PAPILLO
EDEMA 
A 170/
100 
160/
100 
130/
100 
50 1.2 A CHO
L 
ELE 
1
3
8 
4.
0 
NORMAL  
A A GRADE 1 P 190/
100 
160/
100 
150/
90 
43 1 A NIL  1
3
9 
4.
4 
NPR + IN 
V1-V4 
A A GRADE 1 P 190/
120 
180/
100 
140/
90 
34 0.6 NIL  NIL  1
4
5 
3.
4 
NORMAL  
P A GRADE 1 A 190/
100 
170/
90 
150/
80 
29 0.9 NIL NIL  1
4
5 
4.
3 
LVH  
P A GARDE 2 A 180/
100 
160/
100 
150/
100 
45 1.2 NIL  NIL  1
4
5 
3.
6 
NORMAL  
ICRBB 
A A GRADE 2 P 180/
100 
160/
100 
150/
100 
37 0.9 NIL  NIL  1
3
9 
3.
7 
NORMAL  
A A GRADE 1  P 170/
110 
160/
100 
140/
90 
35 1.1 NIL  NIL  1
4
0 
4.
3 
NPR IN 
V1-V4 
LBBB 
PATTERN  
P P GRADE3  A 190/
100 
180/
110 
150/
100 
38 1.6 NIL  TRI
GLY  
1
4
5 
3.
9 
LVH 
A A NORMAL  P 180/
100 
160/
110 
140/
90 
35 0.8 NIL  NIL  1
3
8 
3.
3 
LAFB 
P A GRADE 1 A 190/
100 
160/
100 
140/
90 
35 0.9 NIL  NIL  1
3
9 
3.
5 
NORMAL  
A A GARDE1  A 160/
100 
160/
90 
150/
100 
37 1.2 NIL  TGL 1
4
2 
3.
4 
ST-T 
CHANGES  
ST 
ELEVATI
ON IN 
ANTERIO
R LEADS 
WITH 
RECIPRO
CAL 
CHANGES  
A A GRADE 1 P 160/
110 
150/
100 
140/
90 
37 1.6 NIL  CHO
LES 
1
3
3.
7 
ASYEMM
TRICAL T 
7  WAVE 
INVERSIO
N IN 
ANTERIO
R LEADS  
P A GRADE 4 
PAPILLO
EDEMA   
A 190/
90 
140/
80 
140/
90 
34 1.7 NIL  CHO
LES 
1
3
8 
4.
0 
NORMAL 
A A GRADE 4  A 190/
90 
140/
90 
140/
90 
37 1.4 NIL  NIL  1
4
0 
3.
6 
LVH  
A A GARDE 2 A 180/
90 
140/
80 
140/
70 
41 1.2 NIL  TGL  1
4
9 
3.
4 
ST 
ELEVATI
ON IN V1-
V4 
WITH 
RECIPRO
CAL 
CHANGES 
P A NORMAL  A 180/
90 
130/
90 
120/
90 
43 1.8 NIL  CHO
LES 
1
3
8 
4.
3 
LOW 
VOLTGA
E 
COMPLE
XES 
SINUS 
BRADYC
ARDIA 
P A PAPILLO
EDEMA 
A 178/
86 
144/
92 
130/
198 
35 1.1 NIL  CHO
LES  
1
3
8 
4.
1 
SINUS 
BRADYC
ARDIA  
A A MEDIA 
HAZY  
A 168/
82 
142/
80 
130/
78 
36 1.0 NIL  NIL  1
3
9 
4.
3 
ST 
DEPRESSI
ON IN 
ANERIOR 
LEADS  
AND T 
WAVE 
INVERSIO
N IN 
INFERIO
R LEADS  
P P GRADE1  A 178/
88 
168/
76 
130/
86 
46 1.0 NIL  NIL  1
4
0 
3.
6 
NORMAL  
A A NORMAL  A 164/
84 
140/
68 
130/
80 
45 0.9 NIL NIL  1
4
2 
3.
4 
ST 
ELEVATI
ON IN V5-
V6 & 
L1/AVL  
WITH 
RECIPRO
CAL 
CHANGES 
IN 
INFERIO
R LEADS 
P A MEDIA 
HAZY  
A 164/
98 
168/
70 
140/
68 
42 0.6 NIL  CHO
LES 
1
3
6 
3.
6 
LOW 
VOLTAG
E 
COMPLE
XES  
A A GRADE 1 A 148/
88 
134/
96 
136/
68 
34 0.8 1+ NIL  1
3
6 
3.
6 
ST 
DEPRESI
ON IN 
ANTERIO
R LEADS 
AND T 
WAVE 
INVERSIO
N IN 
SAME 
LEADS  
A A NORMAL  A 148/
68 
138/
70 
120/
70 
36 0.9 2+ NIL  1
4
2 
4.
2 
GLOBAL 
T WAVE 
INVERSIO
N  
ST 
ELEVATI
ON IN 
AVR 
A A NORMAL  A 158/
88 
148/
86 
138/
86 
38 0.6 NIL  TGL  1
4
6 
3.
3 
LVH WIH 
STRAIN 
PATTERN  
P P GARDE 2  A 198/
110 
190/
100 
188/
98 
36 0.6 1+ NIL  1
4
7 
4.
5 
SINUS 
BRADYC
ARDIA  
P A MEDIA 
HAZY  
A 176/
80 
150/
80 
140/
90 
42 2 NIL  NIL  1
4
2 
4.
1 
LOW 
VOLTAG
E 
COMPLE
XES  
ICRBBB 
A A MEDIA 
HAZY  
P 178/
90 
168/
80 
140/
90 
45 1.5 NIL  NIL  1
4
6 
3.
6 
LVH 
WITH 
STARIN 
PATTERN  
A A NORMAL   P 188/
90 
168/
90 
150/
90 
40 1.4 NIL  NIL  1
4
6 
3.
6 
 WAVE 
INVERSIO
N IN 
ANERIOR 
LEADS  
P A PSEUDOP
AHKIA  
A 180/
112 
170/
108 
160/
90 
38 0.8 2+ NIL  1
3
6 
3.
3  
SINUS 
BRADYC
ARDIA  
BIFASICU
LAR 
BLOCK 
P A MEDIA 
HAZY  
A 190/
114 
188/
126 
160/
110 
39 0.9 1+ TGL  1
3
9 
4.
3 
SINUS 
BRADYC
ARDIA  
P A PSEUDOP
HAKIC  
A 190/
116 
180/
120 
170/
112 
40 1.3 1+ CHO
LES  
1
4
0 
4.
4 
LAFB 
P A MEDIA 
HAZY  
P 180/
120 
190/
114 
170/
120 
46 1.6 NIL  NIL  1
4
0 
3.
3 
ST 
ELEVATI
ON IN 
L2L3AVF 
WITH 
POSTERI
OR WALL 
MI 
P A GRADE 2 P 190/
110 
180/
98 
140/
86 
44 1.2 NIL  TGL  1
4
2 
3.
6 
ASYMME
TRICAL T 
WAVE 
INVERSIO
N IN 
ANTERIO
R LEADS  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CXR RENAL 
USG 
ECHO CT SCAN HEAD DIAGNOSIS OUTCOME 
MILD 
CARDIOMEGALY 
NA LVH  NA SHT/CAHD/UA DISCHARED 
NORMAL  NA LVH NA ACC.SHT/ACUTE 
PULMONARY EDEMA 
DISCHARG
ED 
NORMAL  GRADE 
1 MRD 
LVH LEFT CAPSULO 
GANGLIONIC 
HAEMMORRAHGE  
SHT/CVA/HAEMORRHA
GE STROKE  
EXPIRED  
NORMAL  NORMA
L  
HYPOKINESI
A OF LV 
APEX 
NA SHT/CAHD/ACUTE 
AWMI/KILLIP CLASS 2 
DISCHARG
ED 
NORMAL  NA NA INFARCT IN LEFT 
SUBCORTICAL AREA 
SHT/CVA/R 
HEMIPARESIS 
DISCHARG
ED  
NORMAL  NA NA INFARCT IN RIGHT 
INTERNAL CAPSULE  
SHT/CVA/L 
HEMIPARESIS 
DISCHARG
ED  
NORMAL  NA  HYPOKINESI
A OF LV 
APEX 
LVEF 45% 
NA  SHT/ACUTE LVF  DISCHARG
ED  
NORMAL  NA  HYPOKINESI
A OF 
POSTERIOR 
WALL  
NA  SHT/ACUTE AWMI DISCHARG
ED  
NORMAL  NA  NA  LEFT ICH/INTRA 
VENTRICULAR 
EXTENSION   
SHT/CVA/HAEMORRHA
GIC STROKE 
EXPIRED  
MILD 
CARDIOMEGALY 
PULMONARY 
CONGESTION +  
NA HYPOKINESI
A OF  LV  
NA  SHT/LVD  DISCHARG
ED  
NORMAL  NA  NA  NA  SHT/SAH  DISCHARG
ED  
MILD 
CARDIOMEGALY 
NA HYPOKINESI
A OF  RWMA 
LVEF 60% 
NA  SHT/CAHD/ACUTE LVF DISCHARG
ED  
NORMAL  NA RWMA+  NA SHT/CAHD/ACUTE 
AWMI 
DISCHARG
ED  
NORMAL  NA  NA LEFT THALAMIC 
INFARCT  
SHT/L THALAMIC 
INFARCT /LEFT 
HEMIPARESIS 
DISCHARG
ED  
NORMAL  NA  CAHD/GRADE 
1 DIASTOLIC 
DYSFUNCTIO
N  
NA SHT/CAHD/LVD DISCHARG
ED  
NORMAL  NA  NA HAEMMORAHGE IN 
RIGHT FRONTAL 
REGION  
SHT/CVA/ICH EXPIRED 
MOD.CARDIMEGA
LY  
NA  RWMA+/LV 
DIASTOLIC 
DYSFUNCTIO
N  
NA  SHT/TYPE2 
DM/CAHD/LVD 
DISCHARG
ED  
NORMAL NA  MILD 
DIASTOLIC 
DYSFUNCTIO
N  
NA SHT/ACUTE 
PULMONARY EDEMA 
DISCHARG
ED  
NORMAL  NA  NA  HAEMARRHAGIC 
INFRACT SEEN IN 
LEFT THALAMUS & 
LEFT 
CUPSULOGANGLIONI
C REGION  
SHT/CVA/ICH DISCHARG
ED  
NORMAL  NA NA RIGHT BASAL 
GANGLIA INFARCT  
SHT/CVA/LEFT 
HEMIPARESIS 
DISCHARG
ED  
NORMAL  NA  GRADE 2 
DIASTOLIC 
DYSFUNCTIO
N  
NA  SHT/ACUTE 
PULMONARY EDEMA  
DISCHARG
ED  
NORMAL  NA  GRADE 1 
DIASTOLIC 
DYSFUNCTIO
N  
NA  SHT/TYPE 2 DM/CAHD 
OLD ASMI 
 
DISCHARG
ED  
NORMAL  NA  NORMAL  HAEMORRHAGIC SHT/LEFT DISCHARG
INFARCT IN LEFT 
CEREBELLUM   
CEREBELLAR 
HAEMORRHAGE  
ED  
NORMAL  NA  RWMA+/LVEF 
45% 
NA  SHT/CAHD/LV D  DISCHARG
ED  
NORMAL  NA  NA NORMAL STUDY  SHT/CVA/RIGHT  
HEMIPARESIS 
DISCHARG
ED  
NORMAL  NA  NA INFARCT SEEN RIGH 
INERNAL CAPSULE  
SHT/CVA/LEFT 
HEMIPARESIS 
DISCHARG
ED  
NORMAL  NA  TACHYCARDI
A DURING 
STUDY  
LV SYSTOLIC 
FUNCTION 
NORMAL 
DIASTOLIC 
DYSFUNC 
NA SHT/ACUE PULMONARY 
EDEMA 
DISCHARG
ED  
NORMAL  NA NA HAEMMRAHGE 
PRESENT IN THE LEFT 
EMPORAPARIETAL 
REGION  
WIH MIDLINE SHIFT  
ACCELERATED 
SHT/CVA/ICH 
DISCHAGR
ED  
NORMAL  NA  MILD 
DIASTOLIC 
DYSFUNCTIO
N  
PERIVENTRICULAR 
REVERSIBLE 
LEUOENCEPHALOPAT
HY 
ACCELERATED SHT  DISCHARG
ED  
NORMAL  NA HYPOKINESI
A OF LW 
ANTERIOR 
WALL 
LVEF 
ADEQUATE  
NA  ACCELERATED 
SHT/CAHD/ACS/ACUTE 
AWMI?KILLIP CLASS 1 
DISCHARG
ED  
NORMAL  NA  NA  NORMAL STUDY  ACELERATED 
SHT/CVA/ISCHEMIC 
INFARCT /LEFT 
HEMIPARESIS  
DISCHARG
ED 
NORMAL  NA NA CEREBRAL EDEMA  
NO OBVIOUS 
HAMMOARHGE R 
INFARCT  
ACCELERATED 
SHT/HYPERETNSIVE 
ENCEPHALOPATHY  
DICHARGE
D  
MILD 
CARDIOMEGALY  
NA  GRADE 3 
DIASTOLIC 
DYSFUNCTIO
N  
LVEF 50% 
RWMA + 
NA  ACCELERATED 
SHT/CAHD/UNSTABEL 
ANGINA  
DISCHARG
ED  
NORMAL  NA  NA  ICH PRESENT IN THE 
BRAIN STEM  
ACCELERATED 
SHT/CVA/ICH WITH 
INTRAVENTICULAR 
HAEMORRHAGE  
EXPIRED  
NORMAL  NA RWMA + IN 
LV APEX 
LVEF 56% 
DIASTOLIC 
FUNCTION 
NORMAL  
NA  ACCELERATED 
SHT?CAHD/ACS/ACUTE 
LAERAL WALL MI  
DISCHARG
ED  
NORMAL  NA NA  MULTIPLE INFARCT  
PERIVANTRICULAR 
TRANSLUCENCY   
SHT/DYSLIPIDEMIA 
/CVA/MULTI INFARCT 
STATE WITH 
DEMENTIA/RIGHT  
HEMIPARESIS  
DISCHARG
ED  
NORMAL  NA LVH  
GRADE 2 
DIASTOLIC 
DYSFUNCTIO
N 
LV SYSTOLIC 
FUNCTION 
ADEQUATE  
NA  SHT/CAHD/ACS/UNSTAB
LE ANGINA/KILLIP 
CLASS 2 
DISCHARG
ED  
NORMAL  GRADE 
IN MRD 
LV SYSOLIC 
FUNCTION 
ADEQUATE  
GLOBAL 
HYPOKINESI
A  
NA  SHT/CAHD/ACS/UA/?RIP
LE VESSEL DISEASE  
DISCHARG
ED  
NORMAL  NA  LEFT 
VENTRICULA
R 
HYPERTROP
HY  
NA  SHT/ACUTE 
PULMONARY EDEMA  
DISCHARG
ED  
NORMAL  NA  NA  SAH WITH CEREBRAL 
EDEMA  
SHT/SAH/CEREBRAL 
EDEMA  
DISCHARG
ED  
NORMAL  NA  NA  INFARCT IN RIGHT 
MCA TERRITORY  
SHT/CVA/LEFT 
HEMIPARESIS 
DISCHARG
ED  
NORMAL  NA  LEFT 
VENRICULAR 
HYPERTROP
HY  
GRADE 1 
DIASTOLIC 
DYSFUNCTIO
N  
NO RWMA 
LV SYSOLIC 
FUNCTION 
ADEQUATE  
NA  SHT/ACUTE 
PULMONARY EDEMA  
DISCHARG
ED  
NORMAL  NA  HYPOKINESI
A OF LV FREE 
WALL  
LV SYSTOILC 
FUNCTION 
ADEQUATE  
NA SHT/CAHD/ACS/ACUTE 
LATERAL WALL MI 
DISCHARG
ED  
NORMAL  NA  NA MASSIVE INFARCT IN 
LEFT HEMISPHERE 
INO HAEMORRHAGIC 
TRANSMISSION   
SHT/CVA/HAEMAORGH
IC INFARCT 
 
EXPIRED  
 
MILD 
CARDIOMEGALY  
GARDE 
1 MRD 
LVH + 
DIASTOLIC 
DYSFUNCTIO
N GRADE 2 
CEREBRAL EDEMA  SHT/UA/HYPERTENSIVE 
ENCEPHALOPATHY  
DISCHARG
ED  
NORMAL  NA  NA ICH IN RIGHT ABSAL 
GANGLIA  
SHT/CVA/ICH EXPIRED  
NORMAL  NA LVH 
HYPOKINESI
A SEEN IN LV 
POSERIOR 
WALL  
NA  SHT/CAHD/ACS/ACUTE 
INFEROPASTERO WALL 
MI?KILLIP CLASS 2 
DISCHARG
ED  
NORMAL  NA  LVH 
LV SYSOLIC 
FUNCTION 
ADEQUATE  
NA SHT/CAHD/ACS/UA DISCHARG
ED  
NORMAL  NA NA ICH IN LEFT 
HEMISPHERE 
MASSIVE 
HAEMORHHAGE  
SHT/CVA/ICH DISCHARG
ED  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A:   ABSENT  
ACEI:  ANGIOTENSIN CONVERTING ENZYME INHIBITOR 
ACS:  ACUTE CORONARY SYNDROME 
ARB: ANGIOTENSIN RECEPTOR BLOCKERS 
ASMI: ANTEROSEPTAL MYOCARDIAL INFARCTION 
BB:   BETA BLOCKERS 
CAHD:  CORONARY ARTERY HEART DISEASE 
CCB:  CALCIUM CHANNEL BLOCKERS 
CVA:  CEREBROVASCULAR ACCIDENT 
COLES: CHOLESTRELEMIA 
LAFB: LEFT ANTERIOR FASICULAR BLOCK 
LVD: LEFT VENTRICULAR DYSFUNCTION 
LVH:  LEFT VENTRICULAR HYPERTROPHY 
LVEF: LEFT VENTRICULAR EJECTION FRACTION 
MCA: MIDDLE CEREBRAL ARTERY 
NA:   NOT APPLICABLE 
P:   PRESENT  
RWMA:  REGIONAL WALL MOTION ABNORMALITY 
ICH:  INTRACEREBRAL HAEMORRHAGE 
SAH:  SUBARACHNOID HAEMORRHAGE 
SHT:  SYSTEMIC HYPERTENSION  
TGL: TRIGLYCEREDEMIA 
UA:  UNSTABLE ANGINA 
 
 
 
 
 
 
